Metanephrogenic blastema
Metanephrogenic blastema is an embryonic structure that plays a crucial role in the development of the kidney. It is a mass of undifferentiated cells that originate from the mesoderm, one of the three primary germ layers in the very early embryo. The metanephrogenic blastema is involved in the formation of the nephrons, the functional units of the kidney.
Development[edit]
The metanephrogenic blastema is formed during the embryonic period, specifically during the fifth week of gestation. It arises from the intermediate mesoderm, which also gives rise to other structures such as the gonads and the ureteric bud. The interaction between the metanephrogenic blastema and the ureteric bud is crucial for the development of the kidney.
The ureteric bud invades the metanephrogenic blastema and induces it to differentiate into the various components of the nephron, including the glomerulus, the proximal tubule, the loop of Henle, and the distal tubule. This process is regulated by various growth factors and signaling molecules, such as Wnt and FGF.
Clinical significance[edit]
Abnormalities in the development of the metanephrogenic blastema can lead to various congenital kidney diseases, such as renal agenesis (absence of one or both kidneys), renal hypoplasia (underdevelopment of the kidneys), and polycystic kidney disease (formation of multiple cysts in the kidneys). Understanding the molecular mechanisms that regulate the formation and differentiation of the metanephrogenic blastema is therefore crucial for the development of therapeutic strategies for these diseases.
See also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian